May 20, 2020
OpSens - 100,000 Cases Performed with the OptoWire
Mar 05, 2020
Plaque Modification Devices Market to Reach US$ 2.1 Bn by 2027: TMR
Mar 05, 2020
Supira Medical, A Shifamed Portfolio Company, Closes $35M In Series B Financing
Feb 03, 2020
How to Reduce Your Risk for Another Heart Attack
Jan 30, 2020
Genetesis Pilot study: 90-second scan shows promise in evaluating chest pain patients in Emergency Department observation unit
Jan 29, 2020
Fractional Flow Reserve Market to be Driven by Increasing Circumstances of Cardiac Complaints Similar to High Blood Pressure & Coronary Artery Illnesses Till 2026 | Million Insights
Jan 13, 2020
Cardisio Demonstrates Unprecedented Accuracy in New Non-Invasive Coronary Artery Disease Detection
Jan 13, 2020
Opsens Receives FDA Approval of Optowire III
Dec 20, 2019
HealthWell Foundation Launches Fund to Provide Financial Assistance to Medicare Patients with Hypercholesterolemia
Nov 16, 2019
ISCHEMIA-CKD Trial: Advanced Chronic Kidney Disease Patients Treated with Invasive Heart Procedures Show No Reduction in Rate of Cardiac Events
Nov 16, 2019
ISCHEMIA Trial Finds No Evidence of Lower Cardiac Event Rates in Patients Treated with Heart Procedures, but Better Quality of Life
Nov 11, 2019
Multi-Center Clinical Study Demonstrates HeartTrends® Improves Early Detection for Heart Disease in Healthy Individuals
Oct 22, 2019
Heart MRI Delivers Accurate Diagnosis and Helps Guide Treatment of Cardiovascular Diseases
Sep 20, 2019
CathWorks FFRangio(TM) System Featured In TCT 2019 Satellite Program
Sep 04, 2019
New Study Shows EarlySign's Machine Learning Algorithm Can Predict Which Cardiac Patients are at High-Risk Following Discharge
Sep 03, 2019
US Coronary Artery Disease Market and Competitive Landscape Report 2019
Sep 03, 2019
The European Society of Cardiology Includes Neovasc Reducer(TM) for the Treatment of Refractory Angina in the European Practice Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes
Aug 28, 2019
VivaLNK's Wearable ECG Patch Used in Study of Autonomic Function in Predicting Heart Disease
Aug 19, 2019
Global Coronary Stents Market to 2023: Product Launches / Bioresorbable Coronary Stents / Mergers and Acquisitions / Technological Advancements
Jul 15, 2019
FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease